Abstract
Flakka, as the newest member of the synthetic cathinone group, is a substance with serious cardiovascular, neurological, psychiatric, infectious effects and addictive potential. There are only a few case reports and laboratory studies in the literature and there is no dermatological side effects reported yet. We present the first Stevens-Johnson syndrome/Toxic epidermal necrolysis (SJS/TEN) overlap case after Flakka use.
Keywords:
Bath salts; Flakka; Stevens-Johnson syndrome; Synthetic cathinone.
Copyright © 2018 Elsevier Inc. All rights reserved.
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Designer Drugs / adverse effects*
-
Emergency Service, Hospital
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Male
-
Methylprednisolone / therapeutic use
-
Pentanones / adverse effects*
-
Pyrrolidines / adverse effects*
-
Stevens-Johnson Syndrome / drug therapy
-
Stevens-Johnson Syndrome / etiology*
-
Stevens-Johnson Syndrome / pathology
-
Young Adult
Substances
-
Anti-Inflammatory Agents
-
Designer Drugs
-
Immunoglobulins, Intravenous
-
Pentanones
-
Pyrrolidines
-
1-phenyl-2-(1-pyrrolidinyl)-1-pentanone
-
Methylprednisolone